{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:13:50Z","timestamp":1782285230445,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ARD","award":["R01 EY024349-01A1"],"award-info":[{"award-number":["R01 EY024349-01A1"]}]},{"name":"NEI\/NIH","award":["EY01792"],"award-info":[{"award-number":["EY01792"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jtos.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T17:31:29Z","timestamp":1543944689000},"page":"303-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis"],"prefix":"10.1016","volume":"17","author":[{"given":"Sayena","family":"Jabbehdari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor W.","family":"Starnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaliq H.","family":"Kurji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3647-0250","authenticated-orcid":false,"given":"Medi","family":"Eslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7684-3424","authenticated-orcid":false,"given":"Maria S.","family":"Cortina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Djalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtos.2018.12.002_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2013.10.036","article-title":"Atopic keratoconjunctivitis: a review","volume":"70","author":"Chen","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jtos.2018.12.002_bib2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","article-title":"Atopic keratoconjunctivitis","volume":"97","author":"Foster","year":"1990","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2018.12.002_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/ACI.0000000000000299","article-title":"An update on ocular allergy","volume":"16","author":"Shaker","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jtos.2018.12.002_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0161-6420(91)32322-4","article-title":"Clinical features of atopic keratoconjunctivitis","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2018.12.002_bib5","first-page":"21","article-title":"Ocular complications of atopic dermatitis","volume":"19","author":"Garrity","year":"1984","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.12.002_bib6","first-page":"381","article-title":"Ophthalmological changes in atopic dermatitis","volume":"45","author":"Karel","year":"1965","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jtos.2018.12.002_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.iac.2010.06.004","article-title":"Atopic dermatitis and keratoconjunctivitis","volume":"30","author":"Bielory","year":"2010","journal-title":"Immunol Allergy Clin"},{"issue":"4","key":"10.1016\/j.jtos.2018.12.002_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0161-6420(98)94017-9","article-title":"Long-term follow-up of patients with atopic keratoconjunctivitis","volume":"105","author":"Power","year":"1998","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2018.12.002_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICU.0000000000000378","article-title":"Limbal and corneal epithelial homeostasis","volume":"28","author":"Yazdanpanah","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2018.12.002_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtos.2017.11.002","article-title":"The diagnosis of limbal stem cell deficiency","volume":"16","author":"Le","year":"2018","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2018.12.002_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ICU.0000000000000387","article-title":"Diagnosis of corneal limbal stem cell deficiency","volume":"28","author":"Kim","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2018.12.002_bib12","first-page":"677","article-title":"Epithelial transplantation for the management of severe ocular surface disease","volume":"94","author":"Holland","year":"1996","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"10.1016\/j.jtos.2018.12.002_bib13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0161-6420(02)00960-0","article-title":"Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency","volume":"109","author":"Solomon","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2018.12.002_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(00)00475-9","article-title":"Living related conjunctival limbal allograft for the treatment of stem cell deficiency","volume":"108","author":"Daya","year":"2001","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.jtos.2018.12.002_bib15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2013.161","article-title":"Surgical treatment of 32 cases of long-term atopic keratoconjunctivitis using the amniotic membrane","volume":"27","author":"Yang","year":"2013","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.jtos.2018.12.002_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/ICO.0b013e3181cbf9d3","article-title":"Vernal keratoconjunctivitis with limbal stem cell deficiency","volume":"30","author":"Sangwan","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.12.002_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ajo.2017.10.002","article-title":"Long-term outcomes of ocular surface stem cell allograft transplantation","volume":"184","author":"Movahedan","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.12.002_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/ACI.0b013e3282efd0bf","article-title":"Clinical grading of atopic keratoconjunctivitis","volume":"7","author":"Calonge","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2018.12.002_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/ICO.0b013e31822481c2","article-title":"Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis","volume":"31","author":"Tzu","year":"2012","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.12.002_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40123-013-0019-y","article-title":"Management of vernal keratoconjunctivitis","volume":"2","author":"Leonardi","year":"2013","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.jtos.2018.12.002_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00130832-200210000-00010","article-title":"Spectrum of ocular allergy","volume":"2","author":"Trocme","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jtos.2018.12.002_bib22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/112067211002000506","article-title":"Systemic cyclosporin A in severe atopic keratoconjunctivitis","volume":"20","author":"Cornish","year":"2010","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.12.002_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.jtos.2018.12.002_bib24","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ophtha.2013.03.044","article-title":"Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis","volume":"120","author":"Wan","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2018.12.002_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00003226-199309000-00008","article-title":"Topical cyclosporin A in the treatment of anterior segment inflammatory disease","volume":"12","author":"Holland","year":"1993","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2018.12.002_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2018.12.002_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ajo.2013.10.006","article-title":"Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis","volume":"157","author":"Al-Amri","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.12.002_bib28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/01.ico.0000240091.11854.14","article-title":"Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis","volume":"25","author":"Stumpf","year":"2006","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2018.12.002_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/ICO.0b013e3181d83875","article-title":"Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature","volume":"30","author":"Garcia","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.12.002_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2010.2919","article-title":"Omalizumab for severe atopic keratoconjunctivitis","volume":"2010","author":"Taille","year":"2010","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.jtos.2018.12.002_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2332\/allergolint.13-OA-0605","article-title":"Usefulness of a new therapy using rebamipide eyedrops in patients with VKC\/AKC refractory to conventional anti-allergic treatments","volume":"63","author":"Ueta","year":"2014","journal-title":"Allergol Int"},{"issue":"10","key":"10.1016\/j.jtos.2018.12.002_bib32","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ophtha.2014.04.025","article-title":"Medically reversible limbal stem cell disease: clinical features and management strategies","volume":"121","author":"Kim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2018.12.002_bib33","doi-asserted-by":"crossref","first-page":"576712","DOI":"10.1155\/2012\/576712","article-title":"Adverse effects of systemic immunosuppression in keratolimbal allograft","volume":"2012","author":"Krakauer","year":"2012","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.12.002_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ICU.0000000000000386","article-title":"Amniotic membrane use for management of corneal limbal stem cell deficiency","volume":"28","author":"Sabater","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"issue":"22","key":"10.1016\/j.jtos.2018.12.002_bib35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199906033402201","article-title":"Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation","volume":"340","author":"Tsubota","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jtos.2018.12.002_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s40135-017-0119-2","article-title":"Update on the management of high-risk penetrating keratoplasty","volume":"5","author":"Jabbehdari","year":"2017","journal-title":"Curr Ophthalmol Rep"},{"issue":"12","key":"10.1016\/j.jtos.2018.12.002_bib37","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/ICO.0b013e31823f7765","article-title":"Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure","volume":"31","author":"Kang","year":"2012","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.12.002_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192381","article-title":"Five year outcomes of Boston type I keratoprosthesis as primary versus secondary penetrating corneal procedure in a matched case control study","volume":"13","author":"Kang","year":"2018","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.jtos.2018.12.002_bib39","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1398-9995.2012.02818.x","article-title":"The role of Staphylococcal enterotoxin in atopic keratoconjunctivitis and corneal ulceration","volume":"67","author":"Fujishima","year":"2012","journal-title":"Allergy"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418302088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418302088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T20:16:02Z","timestamp":1694463362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012418302088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1542012418302088"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2018.12.002","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}